Tag » Immunology

Complement in basic processes of the cell

Publication date: Available online 3 December 2016
Source:Molecular Immunology
Author(s): Anaïs Jiménez-Reinoso, Ana V. Marin, José R. Regueiro
The complement system is reemerging in the last few years not only as key element of innate immunity against pathogens, but also as a main regulator of local adaptive responses, affecting dendritic cells as well as T and B lymphocytes. 108 kata lagi

By Alexandros G. Sfakianakis

Rapamycin Preferentially Inhibits Human IL-5+ Th2 Cell Proliferation via an mTORC1/S6 Kinase-1 Dependent Pathway

Publication date: Available online 3 December 2016
Source:Journal of Allergy and Clinical Immunology
Author(s): Yuzhi Yin, Alyssa Mitson-Salazar, Daniel L. Wansley, Satya P. Singh, Calman Prussin

http://ift.tt/2fVIqOq

By Alexandros G. Sfakianakis

Association between the CDHR3 rs6967330 risk allele and chronic rhinosinusitis

Publication date: Available online 3 December 2016
Source:Journal of Allergy and Clinical Immunology
Author(s): Eugene H. Chang, Amanda L. Willis, Hilary C. McCrary, George T. Noutsious, Christopher H. 74 kata lagi

By Alexandros G. Sfakianakis

Patterns of constitutively phosphorylated kinases in B cells are associated with disease severity in common variable immunodeficiency

Publication date: Available online 3 December 2016
Source:Clinical Immunology
Author(s): Eli Taraldsrud, Pål Aukrust, Silje Jørgensen, Ole Christian Lingjærde, Johanna Olweus, June H. Myklebust, Børre Fevang… 152 kata lagi

By Alexandros G. Sfakianakis

NFKB1 regulates human NK cell maturation and effector functions

Publication date: Available online 3 December 2016
Source:Clinical Immunology
Author(s): Vassilios Lougaris, Ornella Patrizi, Manuela Baronio, Giovanna Tabellini, Giacomo Tampella, Eufemia Damiati, Natalie Frede, Jos W.M. 161 kata lagi

By Alexandros G. Sfakianakis

Prognostic significance of repeat biopsy in lupus nephritis: Histopathologic worsening and a short time between biopsies is associated with significantly increased risk for end stage renal disease and death

Publication date: Available online 3 December 2016
Source:Clinical Immunology
Author(s): Cristina Arriens, Sixia Chen, David R. Karp, Ramesh Saxena, Kamalanathan Sambandam, Eliza Chakravarty, Judith A. James, Joan T. 455 kata lagi

By Alexandros G. Sfakianakis

Assessing the value of mepolizumab for severe eosinophilic asthma: a cost-effectiveness analysis

Adding mepolizumab to standard treatment with inhaled corticosteroids and controller medications could decrease asthma exacerbations and use of long-term oral steroids in patients with severe disease and increased eosinophils; however, mepolizumab is costly and its cost effectiveness is unknown.

http://ift.tt/2fXPAge

By Alexandros G. Sfakianakis